Primary results from the CLEAR Study were presented at the ESMINT annual meeting in Marseille, France (4-6 September 2023), where Vesalio also announced the fifth anniversary of the international commercialization of the NeVa™ device.
VESALIO announces the successful initial use of its NeVa VS device in the United States for the treatment of post-aneurysmal subarachnoid hemorrhage (aSAH) cerebral vasospasm.
Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology.
MDR certification confirms the company’s commitment of ensuring that their innovative new products meet or exceed these rigorous new standards.
NeVa VS is a patented retrievable nitinol stent specifically designed to treat cerebral vasospasm after aneurysmal rupture.
The first integrated clot micro-filtration technology for stroke thrombectomy patients.
Important follow up tool to share with newly initiated sites for collecting case feedback during evaluation phase. Can be used on an ongoing basis for collecting feedback in willing sites.
enVast Procedure Guide (A1 Poster Format) Download Print Ready Version: enVast A1 Poster Procedure Guide | Download Digital Version: Digital enVast Procedure Guide A1 Poster enVast Procedure Guide (A5 Pocket Guide) Download Print Ready Version: enVast A5 Pocket Guide | Download Digital Version: Digital enVast A5 Pocket Guide The enVast Procedure Guide is…
To be used for presentations to the cath lab staff before enVast use is initiated at a site. Contact Market Development for help if needed. Download Link: Click Here
To be used for initial enVast presentations to targeted customers. Modular: different sections can be used as needed. Contact Market Development for help in obtaining the powerpoint version, getting training, or to organize an enVast Induction Webinar with your customer as needed.